Eli Lilly

The FDA has approved Eli Lilly's Zepbound drug for weight loss. It's set to hit the market by the end of the year. Nancy Chen has more.

The prescription drug, which patients self-inject once a week, is the same medication as Type 2 diabetes treatment Mounjaro, but in different doses to treat ...

U.S. regulators signed off on Eli Lilly's diabetes drug Zepbound, which can also be used to aid weight loss like Wegovy and Ozempic.

The Danish drugmaker's Zepbound will undercut its rivals' pricing by 21% but still cost over $1000 a month.

Eli Lilly gets FDA approval to sell Mounjaro as obesity drug called Zepbound (STAT); Senator floats new models to manage costs of weight loss drugs like ...

Eli Lilly on Thursday said it has not yet gained approval in Britain for the injection pen it plans to use for its Mounjaro drug against obesity and ...

Pharmaceutical company Eli Lilly (NYSE:LLY) investors were in high excitement on Wednesday after the company said it had gained approval from U.K. and U.S. ...

Tirzepatide, the active ingredient in Zepbound for weight loss, is already approved under the trade name Mounjaro for use along with diet and exercise to help ...

in the commercial showdown between the drugmakers' highly effective weight-loss treatments, the newly-approved Zepbound and Wegovy. When Lilly (ticker: LLY) ...